ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study. Taking place in the United States and Japan, the study is designed to assess the safety and efficacy, as well as economic outcomes, of CSI’s new micro crown Orbital Atherectomy System (OAS) in treating severely calcified coronary lesions in patients suffering from Coronary Artery Disease (CAD). Dr. Shigeru Saito, Director of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital, Kamakura, Japan, performed the procedures on October 27.
Help employers find you! Check out all the jobs and post your resume.
